How to buy Taro Pharmaceutical Industries stock (TARO)

Taro Pharmaceutical Industries is a drug manufacturers - specialty & generic business based in the US. Taro Pharmaceutical Industries shares (TARO) are listed on the NYSE and all prices are listed in US Dollars.

Our top picks for where to buy Taro Pharmaceutical Industries stock

Buy Taro Pharmaceutical Industries stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Taro Pharmaceutical Industries stock price (NYSE: TARO)

Use our graph to track the performance of TARO stocks over time.

Taro Pharmaceutical Industries shares at a glance

• Key figures

Information last updated 2024-08-18.

52-week range	$40.45 - $45.76
50-day moving average more info button	$42.53
200-day moving average more info button	$40.34
Wall St. target price	$43.00
PE ratio more info button	30.049
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$1.43

Is it a good time to buy Taro Pharmaceutical Industries stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Taro Pharmaceutical Industries stock undervalued or overvalued?

Valuing Taro Pharmaceutical Industries stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Taro Pharmaceutical Industries's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Taro Pharmaceutical Industries's P/E ratio

Taro Pharmaceutical Industries's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, Taro Pharmaceutical Industries shares trade at around 30x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Taro Pharmaceutical Industries's EBITDA

Taro Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $38.4 million.

The EBITDA is a measure of a Taro Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.

Taro Pharmaceutical Industries financials

Revenue TTM	$629.2 million
Operating margin TTM	5.93%
Gross profit TTM	$293.1 million
Return on assets TTM	0.21%
Return on equity TTM	3.06%
Profit margin	8.56%
Book value	$47.71
Market Capitalization more info button	$1.6 billion

TTM: trailing 12 months

Taro Pharmaceutical Industries share dividends

We're not expecting Taro Pharmaceutical Industries to pay a dividend over the next 12 months.

Have Taro Pharmaceutical Industries's shares ever split?

Taro Pharmaceutical Industries's shares were split on a 2:1 basis on 26 July 2001 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Taro Pharmaceutical Industries shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Taro Pharmaceutical Industries shares which in turn could have impacted Taro Pharmaceutical Industries's share price.

Taro Pharmaceutical Industries share price volatility

Over the last 12 months, Taro Pharmaceutical Industries's shares have ranged in value from as little as $40.45 up to $45.76. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Taro Pharmaceutical Industries's is 0.557. This would suggest that Taro Pharmaceutical Industries's shares are less volatile than average (for this exchange).

Taro Pharmaceutical Industries overview

Taro Pharmaceutical Industries Ltd. , a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel.

Frequently asked questions

What percentage of Taro Pharmaceutical Industries is owned by insiders or institutions?
Currently 78.484% of Taro Pharmaceutical Industries shares are held by insiders and 13.064% by institutions. When does the fiscal year end for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries's fiscal year ends in March. Where is Taro Pharmaceutical Industries based?
Taro Pharmaceutical Industries's address is: 14 Hakitor Street, Haifa, Israel, 2624761 What is Taro Pharmaceutical Industries's ISIN number?
Taro Pharmaceutical Industries's international securities identification number is: USM8737E1084 What is Taro Pharmaceutical Industries's CUSIP number?
Taro Pharmaceutical Industries's Committee on Uniform Securities Identification Procedures number is: M8737E108